Delivery Order 36C24922D0027-36C24926N0622
Award Date 9/23/26
Potential Completion Date 9/22/27
Potential Value $1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Murfreesboro, TN 37129, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $392,628.24 delivery order contract to Caredx, Inc., doing business as Caredx, located in Murfreesboro, Tennessee. The firm fixed price contract is for the period of September 23, 2023 through September 22, 2024 and is for Genetic Blood Testing for Transplant Patients (AlloMap and AlloSure). Caredx will provide their AlloMap and AlloSure products, which are used to help...
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- CareDx, Inc. has been awarded a delivery order valued at $491,742.36 by the Department of Veterans Affairs through Veterans Integrated Service Network 9 (VISN 9) for genetic blood testing services for transplant patients. The contract, which carries a firm fixed-price structure with no set-aside designation, will be performed in Brisbane, California and is scheduled for completion by September 22, 2026. This delivery order falls under CareDx's larger Indefinite Delivery Contract with VISN 9,...
- Veterans Integrated Service Network 23 issued a delivery order to CareDx, Inc. on January 15, 2025, with a ceiling value of $170,445.00 for laboratory services, with an ultimate completion date of January 14, 2026. Place of performance is Brisbane, California. The order is priced on a firm fixed-price basis with no set-aside designation. CareDx specializes in advanced diagnostic solutions for organ transplant patients, including proprietary genetic and molecular testing services such as AlloSure...
- Caredx Lab Solutions Inc. was awarded a firm fixed price delivery order against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 indefinite delivery contract to provide AlloMap molecular testing services. The $6,480 order has a completion date of June 2, 2023 and was awarded on June 3, 2022 to support the VISN's care of veteran transplant recipients in the Dallas, Texas area. The single award IDC, which has a potential value of $675,000 and...
- Veterans Integrated Service Network 21 awarded a $1.25 million definitive contract to CareDx, Inc. for AlloMap and AlloSure post-heart transplant rejection surveillance tests on March 1, 2022, under full-and-open competition with no set-aside. The originating solicitation, posted September 9, 2021, sought five-year indefinite-delivery services to deliver approximately 30 AlloMap and 15 AlloSure blood tests annually to heart transplant recipients in the Palo Alto, California area. The contract...
- CareDx Lab Solutions Inc., headquartered in West Chester, Pennsylvania, was awarded a delivery order valued at $23,972.68 by the Department of Veterans Affairs Veterans Integrated Service Network 17 (VISN 17) on June 3, 2024. This firm fixed-price contract, which carries no set-aside designation, represents a delivery order issued against an existing single-award indefinite delivery contract valued at $787,000 with an ultimate completion date of June 2, 2027. The delivery order calls for the...
- Caredx Lab Solutions Inc. was awarded a delivery order valued at approximately $60K by the Department of Veterans Affairs Veterans Integrated Service Network 17 for AlloMap molecular testing services. This award, issued on June 3, 2026, represents a continuation of an indefinite delivery contract initially established on June 3, 2022, with a total potential value of $787K and an ultimate completion date of June 2, 2027. The contract utilizes a firm fixed-price model with no set-aside...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Caredx Lab Solutions Inc., a for-profit manufacturer of genomics-based solutions for transplant patients. The $59,931.70 contract provides CAREDX ALLOMAP molecular testing services to support post-transplant surveillance and patient management for heart transplant recipients within the VA network. The contract is an indefinite delivery vehicle with a...
- CareDx, Inc., a medical technology company headquartered in Brisbane, California, received a delivery order award from the Department of Veterans Affairs Veterans Integrated Service Network 12 (VISN 12) on February 1, 2026, for transplant testing kits. This firm fixed-price delivery order has a ceiling value of $1.6 million with an ultimate completion date of January 31, 2027. The contract represents a continuation of the VA's reliance on CareDx's specialized diagnostic solutions for organ...
- 36C24922D0027Indefinite Delivery Contract
- 36C24922D0027-36C24926N0622Delivery Order
Veterans Integrated Service Network 9 issued a $1,049,560.80 delivery order to CareDx, Inc. on September 23, 2026, for genetic blood testing for transplant patients using AlloMap and AlloSure diagnostic tests, with performance through September 22, 2027. Place of performance is Murfreesboro, Tennessee. The order is priced on a firm fixed price basis with no set-aside. CareDx operates as a prime contractor without subcontractors and provides proprietary genetic and molecular diagnostic testing services to assess organ rejection risk in transplant recipients across the VA's regional networks.
Generated 8/21/26, 10:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $557.8k | 7/20/26 | |
| Not listed | Not listed | $491.7k | 7/12/26 |